WallStreetZenWallStreetZen
Analyst Ranking
Bottom 11%
#4080 out of 4548 analysts
Average Return
-66.08%
Win Rate
0%0 out of 6
Risk vs Reward
Poor
Good

Matt Larew's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
No Ratings Available
Matt Larew doesn't have any winning ratings in our database

Matt Larew Analyst Color

Get additional color on Matt Larew's coverage of popular stocks

Matt Larew's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Signify Health IncSGFY
2HoldN/AN/ADowngrades
2 years ago
Ginkgo Bioworks Holdings IncDNA
1BuyN/AN/AInitiates Coverage On
3 years ago
Innovage Holding CorpINNV
2HoldN/AN/ADowngrades
3 years ago
Maxcyte IncMXCT
1BuyN/AN/AInitiates Coverage On
3 years ago
Zymergen IncZY
2HoldN/AN/ADowngrades
3 years ago
Twist Bioscience CorpTWST
1BuyN/AN/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.